Clinical Trials Browser

Interventional × Neoplasms × Fenretinide × Clear all

NCT01553071 2022-03-31

Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies

Phase 1 Terminated

Neoplasms, Recurrence

NCT01479192 2018-11-07

Fenretinide in Healthy Young Women at Genetic and Familial Risk

Phase 3 Terminated

Neoplasms